IVAX, Omnicare settle kickback allegations regarding Risperdal
IVAX Pharmaceuticals and Omnicare agreed to resolve allegations that they solicited kickbacks in exchange for encouraging doctors to prescribe Johnson & Johnson's antipsychotic Risperdal to patients at nursing homes, the Justice Department said. Omnicare, which will pay $98 million, denied wrongdoing despite the settlement.
Reuters | 11/03
This story published in FDLI SmartBrief on 11/04/2009
More from SmartBrief:
Pfizer fined $2.3 billion for illegal marketing of 13 drugs
Thursday, September 3, 2009
AstraZeneca agrees to $520M settlement in Seroquel cases
Monday, November 2, 2009
Pfizer unit is fined $1.3B for off-label marketing of 4 drugs
Monday, October 26, 2009
Get stories like these delivered daily for FREE:
|
FDLI SmartBrief
Designed specifically for professionals involved in the food and drug industry, FDLI SmartBrief is a FREE daily e-mail newsletter. It provides the latest need-to-know news and industry information that maximizes your time, giving you an edge over your competition. Learn more |
|